- Home
- EAD vs ABSI Comparison
EAD vs ABSI Comparison
Compare EAD & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EAD | ABSI |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.1M | 357.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | EAD | ABSI |
|---|---|---|
| Price | $6.70 | $2.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $7.98 |
| AVG Volume (30 Days) | 138.7K | ★ 2.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 8.91% | N/A |
| EPS Growth | N/A | ★ 21.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | N/A | $10.72 |
| Revenue Next Year | N/A | $313.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.89 | $2.01 |
| 52 Week High | $7.18 | $5.23 |
Technical Indicators
Market Signals| Indicator | EAD | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 33.02 | 43.48 |
| Support Level | $6.68 | $2.49 |
| Resistance Level | $6.93 | $2.88 |
| Average True Range (ATR) | 0.05 | 0.17 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 44.11 | 40.74 |
Price Performance
Historical ComparisonAbout EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.